News RSS Bioethics News.

02/16/2017

Speedy drug approvals are risky, but drug companies have another idea that’s just terrible

External Link - Source: Los Angeles Times

As with Trump’s proposed elimination of consumer safeguards, environmental-protection measures and financial reforms, the reality is that if his administration proceeds with a wholesale deregulation of the drug industry, the public will be largely undefended against the aggressive and potentially dangerous predations of multibillion-dollar conglomerates.